These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 29449527)
21. miR-1301 inhibits hepatocellular carcinoma cell migration, invasion, and angiogenesis by decreasing Wnt/β-catenin signaling through targeting BCL9. Yang C; Xu Y; Cheng F; Hu Y; Yang S; Rao J; Wang X Cell Death Dis; 2017 Aug; 8(8):e2999. PubMed ID: 28817119 [TBL] [Abstract][Full Text] [Related]
22. [Over-expression of miR-141 inhibits the proliferation, invasion and migration of hepatocellular carcinoma MHCC-97H cells]. Yao B; Xue Y; Liu Z; Xu M; Tu K; Wang J Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Aug; 32(8):1083-7. PubMed ID: 27412940 [TBL] [Abstract][Full Text] [Related]
23. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression. Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879 [TBL] [Abstract][Full Text] [Related]
24. Reduced osteoblast activity in the mice lacking TR4 nuclear receptor leads to osteoporosis. Lin SJ; Ho HC; Lee YF; Liu NC; Liu S; Li G; Shyr CR; Chang C Reprod Biol Endocrinol; 2012 Jun; 10():43. PubMed ID: 22676849 [TBL] [Abstract][Full Text] [Related]
25. C1GALT1 is associated with poor survival and promotes soluble Ephrin A1-mediated cell migration through activation of EPHA2 in gastric cancer. Lee PC; Chen ST; Kuo TC; Lin TC; Lin MC; Huang J; Hung JS; Hsu CL; Juan HF; Lee PH; Huang MC Oncogene; 2020 Mar; 39(13):2724-2740. PubMed ID: 32005975 [TBL] [Abstract][Full Text] [Related]
26. Targeting EphA2 suppresses hepatocellular carcinoma initiation and progression by dual inhibition of JAK1/STAT3 and AKT signaling. Wang H; Hou W; Perera A; Bettler C; Beach JR; Ding X; Li J; Denning MF; Dhanarajan A; Cotler SJ; Joyce C; Yin J; Ahmed F; Roberts LR; Qiu W Cell Rep; 2021 Feb; 34(8):108765. PubMed ID: 33626345 [TBL] [Abstract][Full Text] [Related]
27. CRISPR/Cas9-mediated knockout of NSD1 suppresses the hepatocellular carcinoma development via the NSD1/H3/Wnt10b signaling pathway. Zhang S; Zhang F; Chen Q; Wan C; Xiong J; Xu J J Exp Clin Cancer Res; 2019 Nov; 38(1):467. PubMed ID: 31727171 [TBL] [Abstract][Full Text] [Related]
28. Induction of apolipoprotein E expression by TR4 orphan nuclear receptor via 5' proximal promoter region. Kim E; Yang Z; Liu NC; Chang C Biochem Biophys Res Commun; 2005 Mar; 328(1):85-90. PubMed ID: 15670754 [TBL] [Abstract][Full Text] [Related]
29. Use of miR‑145 and testicular nuclear receptor 4 inhibition to reduce chemoresistance to docetaxel in prostate cancer. Zhu J; Qin P; Cao C; Dai G; Xu L; Yang D Oncol Rep; 2021 Mar; 45(3):963-974. PubMed ID: 33650661 [TBL] [Abstract][Full Text] [Related]
30. Oxidative stress stimulates testicular orphan receptor 4 through forkhead transcription factor forkhead box O3a. Li G; Lee YF; Liu S; Cai Y; Xie S; Liu NC; Bao BY; Chen Z; Chang C Endocrinology; 2008 Jul; 149(7):3490-9. PubMed ID: 18388194 [TBL] [Abstract][Full Text] [Related]
31. Hint1 suppresses migration and invasion of hepatocellular carcinoma cells in vitro by modulating girdin activity. Wu XS; Bao TH; Ke Y; Sun DY; Shi ZT; Tang HR; Wang L Tumour Biol; 2016 Nov; 37(11):14711-14719. PubMed ID: 27623945 [TBL] [Abstract][Full Text] [Related]
32. Ephrin-A3/EphA2 axis regulates cellular metabolic plasticity to enhance cancer stemness in hypoxic hepatocellular carcinoma. Husain A; Chiu YT; Sze KM; Ho DW; Tsui YM; Suarez EMS; Zhang VX; Chan LK; Lee E; Lee JM; Cheung TT; Wong CC; Chung CY; Ng IO J Hepatol; 2022 Aug; 77(2):383-396. PubMed ID: 35227773 [TBL] [Abstract][Full Text] [Related]
33. Activation of TR4 orphan nuclear receptor gene promoter by cAMP/PKA and C/EBP signaling. Liu NC; Lin WJ; Yu IC; Lin HY; Liu S; Lee YF; Chang C Endocrine; 2009 Oct; 36(2):211-7. PubMed ID: 19618297 [TBL] [Abstract][Full Text] [Related]
34. Modulation of the retinoic acid-induced cell apoptosis and differentiation by the human TR4 orphan nuclear receptor. Lee YF; Bao BY; Chang C Biochem Biophys Res Commun; 2004 Oct; 323(3):876-83. PubMed ID: 15381082 [TBL] [Abstract][Full Text] [Related]
35. Thyroid hormone receptor inhibits hepatoma cell migration through transcriptional activation of Dickkopf 4. Chi HC; Liao CH; Huang YH; Wu SM; Tsai CY; Liao CJ; Tseng YH; Lin YH; Chen CY; Chung IH; Wu TI; Chen WJ; Lin KH Biochem Biophys Res Commun; 2013 Sep; 439(1):60-5. PubMed ID: 23958302 [TBL] [Abstract][Full Text] [Related]
36. Toll like receptor 4 facilitates invasion and migration as a cancer stem cell marker in hepatocellular carcinoma. Liu WT; Jing YY; Yu GF; Han ZP; Yu DD; Fan QM; Ye F; Li R; Gao L; Zhao QD; Wu MC; Wei LX Cancer Lett; 2015 Mar; 358(2):136-143. PubMed ID: 25511737 [TBL] [Abstract][Full Text] [Related]
37. Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma. Xia L; Huang W; Tian D; Zhu H; Zhang Y; Hu H; Fan D; Nie Y; Wu K J Hepatol; 2012 Sep; 57(3):600-12. PubMed ID: 22613004 [TBL] [Abstract][Full Text] [Related]
38. Regulator of Calcineurin 1 Gene Isoform 4, Down-regulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Metastasis of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1. Jin H; Wang C; Jin G; Ruan H; Gu D; Wei L; Wang H; Wang N; Arunachalam E; Zhang Y; Deng X; Yang C; Xiong Y; Feng H; Yao M; Fang J; Gu J; Cong W; Qin W Gastroenterology; 2017 Sep; 153(3):799-811.e33. PubMed ID: 28583823 [TBL] [Abstract][Full Text] [Related]
39. Dysregulated Krüppel-like factor 4 and vitamin D receptor signaling contribute to progression of hepatocellular carcinoma. Li Q; Gao Y; Jia Z; Mishra L; Guo K; Li Z; Le X; Wei D; Huang S; Xie K Gastroenterology; 2012 Sep; 143(3):799-810.e2. PubMed ID: 22677193 [TBL] [Abstract][Full Text] [Related]
40. Positive feedback loop of FAM83A/PI3K/AKT/c-Jun induces migration, invasion and metastasis in hepatocellular carcinoma. Liu C; Peng X; Li Y; Liu S; Hou R; Zhang Y; Zuo S; Liu Z; Luo R; Li L; Fang W Biomed Pharmacother; 2020 Mar; 123():109780. PubMed ID: 31901550 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]